Accretion Pharmaceuticals Limited (NSE:ACCPL)
India · Delayed Price · Currency is INR 200.00
-2.00 (-0.99%)
At close: Sep 4, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 2.22 billion as of September 4, 2026. Its market cap has increased by 220.77% in one year.
Market Cap
2.22B
Enterprise Value
2.31B
Revenue
896.27M
Ranking
n/a
PE Ratio
22.15
Stock Price
200.00
ChartMarket Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has increased from 922.07M to 2.22B, an increase of 141.11%. That is a compound annual growth rate of 97.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 2.22B | 127.66% |
| Dec 31, 2025 | 976.54M | 5.91% |
| May 21, 2025 | 922.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BDH Industries | 2.98B |
| Gennex Laboratories | 2.94B |
| Astonea Labs | 2.82B |
| Everest Organics | 2.65B |
| Bilcare | 2.36B |
| Sanjivani Paranteral | 2.33B |
| Kerala Ayurveda | 2.30B |
| Bio Medica Laboratories | 2.23B |